Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache

The psychopathological profile of patients with medication overuse headache (MOH) appears to be particularly complex. To better define it, we evaluated their performance on a targeted psychological profile assessment. We designed a case-control study comparing MOH patients and matched healthy contro...

Full description

Bibliographic Details
Main Authors: Simone Migliore, Matteo Paolucci, Livia Quintiliani, Claudia Altamura, Sabrina Maffi, Giulia D’Aurizio, Giuseppe Curcio, Fabrizio Vernieri
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Human Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnhum.2020.571035/full
id doaj-50830f81d4e34f1b8dd2e7a958f5e5b7
record_format Article
spelling doaj-50830f81d4e34f1b8dd2e7a958f5e5b72020-12-08T08:40:13ZengFrontiers Media S.A.Frontiers in Human Neuroscience1662-51612020-11-011410.3389/fnhum.2020.571035571035Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse HeadacheSimone Migliore0Matteo Paolucci1Livia Quintiliani2Claudia Altamura3Sabrina Maffi4Giulia D’Aurizio5Giuseppe Curcio6Fabrizio Vernieri7Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyUOS Cefalee e Neurosonologia, Neurology, University Campus Bio-Medico, Rome, ItalyPsychology Service, University Campus Bio-Medico, Rome, ItalyUOS Cefalee e Neurosonologia, Neurology, University Campus Bio-Medico, Rome, ItalyHuntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyUOS Cefalee e Neurosonologia, Neurology, University Campus Bio-Medico, Rome, ItalyThe psychopathological profile of patients with medication overuse headache (MOH) appears to be particularly complex. To better define it, we evaluated their performance on a targeted psychological profile assessment. We designed a case-control study comparing MOH patients and matched healthy controls (HC). Headache frequency, drug consumption, HIT-6, and MIDAS scores were recorded. All participants filled in the following questionnaires: Beck Depression Inventory-II Edition (BDI-2), trait subtest of State-Trait Anxiety Inventory (STAI-Y), Difficulties in Emotion Regulation Scale (DERS), Barratt Impulsiveness Scale (BIS-11), Toronto Alexithymia Scale (TAS-20). The primary endpoint was to establish if MOH patients have an altered psychopathological profile. The secondary endpoint was to establish whether the worst profile correlates with the worsening of headache and disability measures. We enrolled 48 consecutive MOH patients and 48 HC. MOH patients showed greater difficulty in recognition/regulation of emotions (DERS, TAS-20), depression (BDI-2), anxiety (STAI-Y), and impulsiveness (BIS-11). We found a positive correlation among DERS, BDI-2, STAI-Y, and BIS scores and MIDAS and HIT-6 scores and among DERS and headache frequency and drug consumption. MOH patients showed a high rate of emotion regulation difficulties, depression, and anxiety, which may negatively affect their headaches. The ability to regulate/recognize emotions may play a central role in sustaining medication overuse.https://www.frontiersin.org/articles/10.3389/fnhum.2020.571035/fullemotion regulationemotion recognition (ER)psychopatological profilemedication overuse headache (MOH)behavioral approach
collection DOAJ
language English
format Article
sources DOAJ
author Simone Migliore
Matteo Paolucci
Livia Quintiliani
Claudia Altamura
Sabrina Maffi
Giulia D’Aurizio
Giuseppe Curcio
Fabrizio Vernieri
spellingShingle Simone Migliore
Matteo Paolucci
Livia Quintiliani
Claudia Altamura
Sabrina Maffi
Giulia D’Aurizio
Giuseppe Curcio
Fabrizio Vernieri
Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
Frontiers in Human Neuroscience
emotion regulation
emotion recognition (ER)
psychopatological profile
medication overuse headache (MOH)
behavioral approach
author_facet Simone Migliore
Matteo Paolucci
Livia Quintiliani
Claudia Altamura
Sabrina Maffi
Giulia D’Aurizio
Giuseppe Curcio
Fabrizio Vernieri
author_sort Simone Migliore
title Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
title_short Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
title_full Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
title_fullStr Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
title_full_unstemmed Psychopathological Comorbidities and Clinical Variables in Patients With Medication Overuse Headache
title_sort psychopathological comorbidities and clinical variables in patients with medication overuse headache
publisher Frontiers Media S.A.
series Frontiers in Human Neuroscience
issn 1662-5161
publishDate 2020-11-01
description The psychopathological profile of patients with medication overuse headache (MOH) appears to be particularly complex. To better define it, we evaluated their performance on a targeted psychological profile assessment. We designed a case-control study comparing MOH patients and matched healthy controls (HC). Headache frequency, drug consumption, HIT-6, and MIDAS scores were recorded. All participants filled in the following questionnaires: Beck Depression Inventory-II Edition (BDI-2), trait subtest of State-Trait Anxiety Inventory (STAI-Y), Difficulties in Emotion Regulation Scale (DERS), Barratt Impulsiveness Scale (BIS-11), Toronto Alexithymia Scale (TAS-20). The primary endpoint was to establish if MOH patients have an altered psychopathological profile. The secondary endpoint was to establish whether the worst profile correlates with the worsening of headache and disability measures. We enrolled 48 consecutive MOH patients and 48 HC. MOH patients showed greater difficulty in recognition/regulation of emotions (DERS, TAS-20), depression (BDI-2), anxiety (STAI-Y), and impulsiveness (BIS-11). We found a positive correlation among DERS, BDI-2, STAI-Y, and BIS scores and MIDAS and HIT-6 scores and among DERS and headache frequency and drug consumption. MOH patients showed a high rate of emotion regulation difficulties, depression, and anxiety, which may negatively affect their headaches. The ability to regulate/recognize emotions may play a central role in sustaining medication overuse.
topic emotion regulation
emotion recognition (ER)
psychopatological profile
medication overuse headache (MOH)
behavioral approach
url https://www.frontiersin.org/articles/10.3389/fnhum.2020.571035/full
work_keys_str_mv AT simonemigliore psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT matteopaolucci psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT liviaquintiliani psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT claudiaaltamura psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT sabrinamaffi psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT giuliadaurizio psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT giuseppecurcio psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
AT fabriziovernieri psychopathologicalcomorbiditiesandclinicalvariablesinpatientswithmedicationoveruseheadache
_version_ 1724390398745378816